Wańkowicz Z, Syzdół P, Sułek K
Klinicznego Oddziału Dializoterapii IMW CSK WAM, Warszawa.
Pol Arch Med Wewn. 1991 Jun;85(6):396-406.
6 patients with symptomatic renal anaemia treated with haemodialysis (3F, 3M, aged 41 +/- 17 years) were given r-Hu EPO in initial dose of 50 U/kg, modified during the treatment, according to the Hkt, and Hgb values. Some biochemical and rheological properties of blood taken before treatment showed: normochromic and normocytic anemia with Hkt 22.7 +/- 1.7% Hgb 6.81 +/- 1.6 g% and normal reticulocytosis: significant (p less than 0.001) decrease of whole blood viscosity (WBV) at low shear rate (2.25 x sec-1) and high shear rate (225 x sec-1) related to Hkt values, and significant increase of red celles aggregation (RCA) (p less than 0.02) in comparison to healthy persons. Plasma viscosity (PV), serum fibrinogen, protein and albumin were normal. In 4 patients treated with r-Hu EPO for 12 weeks at least, we observed an increase Hkt to 36.7 +/- 2% and Hgb to 11.2 +/- 1.2 g% and a significant increase of WBV at high shear rate (p less than 0.05), normalization of RCA and improvement of the filtrability of whole blood. No side effects were observed, especially insufficient control of blood pressure. Our preliminary results indicate that our treatment of renal anemia with r-Hu EPO was clinically effective, safe and had positive influence on blood rheology.
6例接受血液透析治疗的症状性肾性贫血患者(3名女性,3名男性,年龄41±17岁)初始剂量给予重组人促红细胞生成素(r-Hu EPO)50 U/kg,治疗期间根据血细胞比容(Hkt)和血红蛋白(Hgb)值进行调整。治疗前采集的血液的一些生化和流变学特性显示:正色素正细胞性贫血,血细胞比容为22.7±1.7%,血红蛋白为6.81±1.6 g%,网织红细胞计数正常;与血细胞比容值相关的低剪切率(2.25×秒-1)和高剪切率(225×秒-1)下全血粘度(WBV)显著降低(p<0.001),与健康人相比,红细胞聚集(RCA)显著增加(p<0.02)。血浆粘度(PV)、血清纤维蛋白原、蛋白质和白蛋白均正常。在至少接受r-Hu EPO治疗12周的4例患者中,我们观察到血细胞比容增加至36.7±2%,血红蛋白增加至11.2±1.2 g%,高剪切率下全血粘度显著增加(p<0.05),红细胞聚集正常化,全血滤过性改善。未观察到副作用,尤其是血压控制不佳的情况。我们的初步结果表明,我们用r-Hu EPO治疗肾性贫血在临床上是有效的、安全的,并且对血液流变学有积极影响。